Table 1.
METTL1 regulated tumor progression by confirmed association with m7G
| Tumors | Role in tumors | m7G target | Mechanisms | Reference |
|---|---|---|---|---|
| Head and neck cancer | accelerator | tRNA | activated the PI3K/Akt/mTORC signaling pathway, RPTOR/ULK1/autophagy axis, and Wnt/β-catenin pathway, as well as promoted the cyclin D1 translation | 44,45 |
| Lung cancer | accelerator | tRNA | promoted translation of cell-cycle genes including cyclin D3 and cyclin E1 | 32 |
| suppressor | miRNA | promoted transcription of let-7e miRNA and inhibited expression of HMGA2 | 19 | |
| Liver cancer | accelerator | tRNA | promoted the translation of cell-cycle genes including cyclin A2, cyclin D2, CDK6, and CDK8 as well as activated EGFR, VEGFA, and MAPK signaling pathways | 52,54 |
| Colon cancer | suppressor | miRNA | promoted transcription of let-7e miRNA and inhibited expression of HMGA2 | 56 |
| Bladder cancer | accelerator | tRNA | promoted the translation of EGFR and EFEP1 and activated EGFR pathway | 59 |
| Teratoma | suppressor | tRNA | promoted translation of pluripotency genes, including Oct4, Nanog, and Sox2, as well as activated cell-cycle signaling pathway | 29 |